Showing results (1-10 of 700) with videos related to
Sort By:
Pageof 70
Cancer Cell|September 13, 2011
Cancer biomarkers: closer to delivering on their promiseLance A Liotta, Emanuel PetricoinDisease Markers|June 11, 2010
Monitoring proteins and protein networks using reverse phase protein arraysBridget Wilson, Lance A Liotta, Emanuel PetricoinJournal of Proteome Research|April 29, 2004
Clinical proteomics: revolutionizing disease detection and patient tailoring therapyEmanuel Petricoin, Julia Wulfkuhle, Virginia Espina, et al.Proteomics|March 5, 2004
Ovarian cancer detection by logical analysis of proteomic dataGabriela Alexe, Sorin Alexe, Lance A Liotta, et al.Advances in Experimental Medicine and Biology|December 11, 2019
RPPA: Origins, Transition to a Validated Clinical Research Tool, and Next Generations of the TechnologyEmanuel Petricoin, Julie Wulfkuhle, Marissa Howard, et al.Biomedical Microdevices|September 21, 2004
Opportunities for nanotechnology-based innovation in tissue proteomicsDavid H Geho, Nicholas Lahar, Mauro Ferrari, et al.Expert Review of Proteomics|October 5, 2021
Laser Capture Proteomics: spatial tissue molecular profiling from the bench to personalized medicineLance A Liotta, Philip A Pappalardo, Alan Carpino, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|February 10, 2004
Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarrayHongbin Zha, Mark Raffeld, Lu Charboneau, et al.International Journal of Oncology|December 7, 2010
Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemiaTullia Maraldi, Jessika Bertacchini, Marta Benincasa, et al.Proceedings of the National Academy of Sciences of the United States of America|October 4, 2007
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenanceJiangbing Zhou, Julia Wulfkuhle, Hao Zhang, et al.Pageof 70